Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Deborah J Donnell"'
Autor:
Sarah E. Stansfield, Jesse Heitner, Kate M. Mitchell, Carla M. Doyle, Rachael M. Milwid, Mia Moore, Deborah J. Donnell, Brett Hanscom, Yiqing Xia, Mathieu Maheu‐Giroux, David van de Vijver, Haoyi Wang, Ruanne Barnabas, Marie‐Claude Boily, Dobromir T. Dimitrov
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss S2, Pp n/a-n/a (2023)
Abstract Introduction Long‐acting injectable cabotegravir (CAB‐LA) demonstrated superiority to daily tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) for HIV pre‐exposure prophylaxis (PrEP) in the HPTN 083/084 trials. We compared the poten
Externí odkaz:
https://doaj.org/article/df10795ebc5f49f7b240cd91573f9f11
Autor:
Sarah E. Stansfield, Mia Moore, Marie-Claude Boily, James P. Hughes, Deborah J. Donnell, Dobromir T. Dimitrov
Publikováno v:
EClinicalMedicine, Vol 56, Iss , Pp 101776- (2023)
Summary: Background: Daily and on-demand pre-exposure prophylaxis (PrEP) are effective at preventing HIV acquisition among men who have sex with men (MSM), but only daily PrEP is approved in the US. On-demand PrEP may improve uptake and adherence. We
Externí odkaz:
https://doaj.org/article/b7f94aa306f64619b62639ca27527f91
Autor:
Geetha Beauchamp, Sybil Hosek, Deborah J Donnell, Kwun C G Chan, Brian P Flaherty, Peter L Anderson, Bonnie J Dye, Nyaradzo Mgodi, Linda-Gail Bekker, Sinead Delany-Moretlwe, Connie Celum, HPTN 082 study team
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0281728 (2023)
BackgroundAfrican adolescent girls and young women (AGYW) represent a large proportion of new HIV infections, a priority population for pre-exposure prophylaxis (PrEP), but adherence remains a challenge. A reliable, valid readiness tool would help id
Externí odkaz:
https://doaj.org/article/abbdebb8d6c149b692805cb25958e077
Autor:
Connie Celum, Sybil Hosek, Mandisa Tsholwana, Sheetal Kassim, Shorai Mukaka, Bonnie J Dye, Subash Pathak, Nyaradzo Mgodi, Linda-Gail Bekker, Deborah J Donnell, Ethan Wilson, Krista Yuha, Peter L Anderson, Yaw Agyei, Heather Noble, Scott M Rose, Jared M Baeten, Jessica M Fogel, Adeola Adeyeye, Lubbe Wiesner, James Rooney, Sinead Delany-Moretlwe
Publikováno v:
PLoS Medicine, Vol 18, Iss 6, p e1003670 (2021)
BackgroundPre-exposure prophylaxis (PrEP) is highly effective and an important prevention tool for African adolescent girls and young women (AGYW), but adherence and persistence are challenging. PrEP adherence support strategies for African AGYW were
Externí odkaz:
https://doaj.org/article/bbd3c1417eb942db943fd1b3c7f283a2
Autor:
William J M Probert, Rafael Sauter, Michael Pickles, Anne Cori, Nomtha F Bell-Mandla, Justin Bwalya, Lucie Abeler-Dörner, Peter Bock, Deborah J Donnell, Sian Floyd, David Macleod, Estelle Piwowar-Manning, Timothy Skalland, Kwame Shanaube, Ethan Wilson, Blia Yang, Helen Ayles, Sarah Fidler, Richard J Hayes, Christophe Fraser, Richard Hayes, Nulda Beyers, Wafaa El-Sadr, Myron Cohen, Susan Eshleman, Yaw Agyei, Virginia Bond, Graeme Hoddinott, Deborah Donnell, Lynda Emel, Heather Noble, David Burns, Nirupama Sista, Sam Griffith, Ayana Moore, Tanette Headen, Rhonda White, Eric Miller, James Hargreaves, Katharina Hauck, Ranjeeta Thomas, Mohammed Limbada, Kalpana Sabapathy, Ab Schaap, Rory Dunbar, Musonda Simwinga, Peter Smith, Sten Vermund, Nomtha Mandla, Nozizwe Makola, Anneen van Deventer, Anelet James, Karen Jennings, James Kruger, Mwelwa Phiri, Barry Kosloff, Lawrence Mwenge, Sarah Kanema, William Probert, Ramya Kumar, Ephraim Sakala, Andrew Silumesi, Tim Skalland, Krista Yuhas
Publikováno v:
e780
e771
e771
Background The long-term impact of universal home-based testing and treatment as part of universal testing and treatment (UTT) on HIV incidence is unknown. We made projections using a detailed individual-based model of the effect of the intervention
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05c5fe31b9ffd9ed588c38c3ec97821b
https://doi.org/10.1016/s2352-3018(22)00259-4
https://doi.org/10.1016/s2352-3018(22)00259-4
Autor:
Sahar Z. Zangeneh, Ethan A. Wilson, Surabhi Ahluwalia, Deborah J. Donnell, Ying Q. Chen, Beatriz Grinsztejn, Marineide G. Melo, Sheela V. Godbole, Mina C. Hosseinipour, Taha Taha, Johnston Kumwenda, Marybeth McCauley, Myron S. Cohen, Karin Nielsen-Saines
Publikováno v:
AIDS care.
HPTN 052 was a multi-country clinical trial of cART for preventing heterosexual HIV-1 transmission. The study allowed participation of pregnant women and provided access to cART and contraceptives. We explored associations between pregnancy and clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39b50cbf99190004a749a49c2744541e
https://pubmed.ncbi.nlm.nih.gov/36524872
https://pubmed.ncbi.nlm.nih.gov/36524872
Autor:
Kate M. Mitchell, Marie-Claude Boily, Brett Hanscom, Mia Moore, Jeffery Todd, Gabriela Paz-Bailey, Cyprian Wejnert, Albert Liu, Deborah J. Donnell, Beatriz Grinsztejn, Raphael J. Landovitz, Dobromir T. Dimitrov
Background: The HPTN 083 trial demonstrated superiority of HIV pre-exposure prophylaxis (PrEP) containing long-acting injectable cabotegravir (CAB) to daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) among men who have sex with men (M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3a2f9942bb6a0caa31d2c195400248d
http://hdl.handle.net/10044/1/102089
http://hdl.handle.net/10044/1/102089
Autor:
Sarah E. Stansfield, Mia Moore, Marie-Claude Boily, James P. Hughes, Deborah J. Donnell, Dobromir T. Dimitrov
Publikováno v:
EClinicalMedicine. 56
Background Daily and on-demand pre-exposure prophylaxis (PrEP) are effective at preventing HIV acquisition among men who have sex with men (MSM), but only daily PrEP is approved in the US. On-demand PrEP may improve uptake and adherence. We identify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8407529f21751818f7e9da98eeecdfa8
https://pubmed.ncbi.nlm.nih.gov/36618897
https://pubmed.ncbi.nlm.nih.gov/36618897
Autor:
Brett S Hanscom, Deborah J Donnell, Thomas R Fleming, James P Hughes, Marybeth McCauley, Beatriz Grinsztejn, Raphael J Landovitz, Scott S Emerson
Publikováno v:
Clin Trials
Background/Aims: The HIV Prevention Trials Network 083 trial was a group-sequential non-inferiority trial designed to compare HIV incidence under a novel experimental regimen for HIV prevention, long-acting injectable cabotegravir, with an active-con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2635b744d1e45de9b059a37f02b49fef
https://europepmc.org/articles/PMC9691580/
https://europepmc.org/articles/PMC9691580/
Autor:
Cantos, Valeria D1 (AUTHOR) vcantos@emory.edu, Neradilek, Moni2 (AUTHOR), Huang, Yunda2 (AUTHOR), Roxby, Alison C2,3 (AUTHOR), Gillespie, Kevin2 (AUTHOR), deCamp, Allan C2 (AUTHOR), Karuna, Shelly T2 (AUTHOR), Edupuganti, Srilatha1 (AUTHOR), Gallardo-Cartagena, Jorge4 (AUTHOR), Sanchez, Jorge4 (AUTHOR), Rio, Carlos del1 (AUTHOR), Veloso, Valdilea5 (AUTHOR), Cohen, Myron S6 (AUTHOR), Donnell, Deborah J1 (AUTHOR), Corey, Lawrence2 (AUTHOR), Kelley, Colleen F1 (AUTHOR)
Publikováno v:
Open Forum Infectious Diseases. Jul2024, Vol. 11 Issue 7, p1-8. 8p.